Novo Nordisk Licenses Experimental Once-Weekly Obesity Pill From China's Hengrui in Deal Worth Up to $2.6 Billion Medical Daily 16:28 Thu, 01 Oct
Novo outlays $2.6bn in Hengrui deal to bolster oral obesity pipeline Pharmaceutical Technology 19:11 Tue, 29 Sep
Eli Lilly obesity drug data adds pressure on Novo Nordisk Proactive Investors (US) 07:38 Fri, 02 Oct Novo Nordisk Mounjaro Pharma All sources
Ozempic and Zepbound makers report slower aging clocks, but unreviewed data do not prove patients age slower Medical Daily 6d Novo Nordisk Ozempic Mounjaro All sources
Eli Lilly sues more vendors selling ‘Illicit’ weight loss drugs Bloomberg Law 6d Obesity Pharma Health All sources
FDA approves expanded indication for Lilly’s Jaypirca Pharmaceutical Business Review 11:14 Mon, 05 Oct Blood Cancer FDA Pharma All sources
Eli Lilly and vs. Novo Nordisk A/s: Which healthcare stock is a better buy in 2026? The Motley Fool 14:18 Tue, 06 Oct Eli Lilly Pharma Amycretin All sources
Patients who switched from weight-loss shots to the Wegovy pill lost 4.1% of body weight in three months Medical Daily 19:56 Fri, 02 Oct Amycretin Ozempic Pharma All sources
Novo-Funded Analysis Ties Raising Ozempic to 2 mg to Slightly Lower Heart Risk Than Switching to Mounjaro Medical Daily 02:25 Thu, 01 Oct Mounjaro Ozempic Pharma All sources
Eli Lilly obesity drug data adds pressure on Novo Nordisk Proactive Investors (US) 07:38 Fri, 02 Oct Eli Lilly Obesity NYSE
Eli Lilly and vs. Novo Nordisk A/s: Which healthcare stock is a better buy in 2026? The Motley Fool 14:18 Tue, 06 Oct Novo Nordisk Eli Lilly Pharma All sources
Liver fat fell to normal in 23 of 26 adults with obesity in small Wegovy post hoc analysis Medical Daily 13:40 Sat, 03 Oct Novo Nordisk Ozempic Obesity All sources
[News Analysis] Wegovy's insurance bid puts Korea's obesity drug prices, prescribing practices under scrutiny Korea Biomedical Review 8h Obesity Ozempic Tirzepatide
China's Hengrui licenses weight-loss drug to Denmark's Novo Nordisk in deal worth up to $2.6B Anadolu Agency 09:50 Tue, 29 Sep Hengrui All sources
Over 10,000 treated for vision, gallbladder, pancreatic and kidney problems after Wegovy, Mounjaro prescriptions Korea Biomedical Review 7h Ozempic Pharma Biotech
Striking weight loss seen with combo drug in diabetes trial Medpage Today 22:35 Thu, 01 Oct Tirzepatide Health Global Health
Mounjaro and alcohol: Pharmacist warns against dismissing serious symptoms as a hangover Wellbeing News 14:33 Mon, 05 Oct Tirzepatide
Change lifestyle before giving children weight loss medication, WHO says Pharmaceutical Technology 6d WHO Tirzepatide Global Health All sources
Roche adds another obesity drug with $1.16bn Rona deal pharmaphorum 1d Rona Therapeutics Roche Pharma
Cutting sugary drinks helps reduce childhood obesity, study finds News-Medical.Net 5d Global Health All sources
Wegovy seeks health insurance coverage, bringing public funding for obesity drugs to the fore Asia Today 14h Ozempic Korean Economy Global Health All sources
